S Gastrointestinal And Liver Disease 12th Edition Hot _top_ Jun 2026

Focuses heavily on immune checkpoint inhibitor (ICI) toxicities. It offers precise grading and biological management algorithms for treating severe, refractory colitis caused by anti-PD-1 or anti-CTLA-4 agents. 4. Advanced Biologics and Small Molecules for IBD

The is an essential reference for medical professionals. It balances classic foundational pathophysiology with modern clinical updates like AI diagnostics, advanced IBD therapeutics, and updated hepatology guidelines.

: Comprehensive data on the long-term GI and hepatic manifestations of the pandemic. Key Clinical Pillars 1. Inflammatory Bowel Disease (IBD)

Updated chapters cover the rapidly evolving landscape of pharmacological agents for MASH, moving beyond lifestyle modification to novel targeting therapies (e.g., resmetirom), with detailed diagnostic insights on non-invasive fibrosis assessment (e.g., FIB-4, VCTE/FibroScan). 2. Advanced Endoscopy and Artificial Intelligence (AI) s gastrointestinal and liver disease 12th edition hot

For GI fellows, transplant hepatologists, advanced endoscopists, and internal medicine specialists, keeping up with the "hot" topics in this edition is vital for board preparation and daily clinical practice. Key Book Specifications

The field of gastroenterology changes rapidly due to advances in molecular biology, targeted therapies, and computer-aided diagnostics. The 12th edition adapts to these shifts through several major updates. 1. Next-Generation Editorial Leadership

: New insights into how bacterial ecosystems influence systemic health and disease. Advanced Biologics and Small Molecules for IBD The

The book is enhanced by over 1,100 full-color illustrations, including radiographs, endoscopic images, and histological photomicrographs.

This is for informational purposes only. For medical advice or diagnosis, consult a professional. AI responses may include mistakes. Learn more

Every chapter follows a consistent format, allowing for rapid retrieval of information regarding epidemiology, pathophysiology, diagnosis, and treatment. Key Clinical Pillars 1

Raymond T. Chung, MD; David T. Rubin, MD; C. Mel Wilcox, MD, MSPH Publication Date December 10, 2025 Print Length 2,560 Pages (2-Volume Set) ISBN-13 978-0443116575 Visual Assets

The textbook covers the extensive array of new treatments, including JAK inhibitors and IL-23 inhibitors, helping clinicians navigate the complex choice of advanced therapies.